wadegarret
2 minutes ago
KIK- CRVO
Why did the stock go from $2.50 to $10 to begin with ? After their failed drug, they have nothing but $5/share net assets. In the meantime, a company like GERN, which has FDA approval & EU approval, for one of only two drugs in the world to treat a deadly blood cancer(w